LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

Search

Fulgent Genetics Inc

Chiusa

SettoreSettore sanitario

20.31 -0.78

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

20.08

Massimo

20.32

Metriche Chiave

By Trading Economics

Entrata

-5.7M

-12M

Vendite

-2.8M

73M

EPS

0.04

Margine di Profitto

-16.197

Dipendenti

1,313

EBITDA

-2M

-12M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+10.48% upside

Dividendi

By Dow Jones

Utili prossimi

1 ago 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

74M

646M

Apertura precedente

21.09

Chiusura precedente

20.31

Punteggio Tecnico

By Trading Central

Fiducia

Bearish Evidence

Fulgent Genetics Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

23 mag 2025, 20:33 UTC

Acquisizioni, Fusioni, Takeovers

Salesforce in Talks to Buy Informatica, Bloomberg Reports, Citing Sources

24 mag 2025, 08:20 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

24 mag 2025, 08:20 UTC

Discorsi di Mercato

Auto & Transport Roundup: Market Talk

24 mag 2025, 07:00 UTC

Utili

Retailers Are Giving Mixed Messages on Prices. What Will s Really Happen at Checkout. -- Barrons.com

23 mag 2025, 21:57 UTC

Azioni calde

Stocks to Watch: Apple, Booz Allen, Constellation Energy, Intuit -- WSJ

23 mag 2025, 21:15 UTC

Notizie principali

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- 4th Update

23 mag 2025, 21:04 UTC

Acquisizioni, Fusioni, Takeovers

Real-Estate Broker Douglas Elliman Could See Takeover Battle After Report of Bid -- Barrons.com

23 mag 2025, 20:56 UTC

Notizie principali
Acquisizioni, Fusioni, Takeovers

Salesforce Back in Deal Talks With Informatica -- WSJ

23 mag 2025, 20:51 UTC

Notizie principali

Boeing in Tentative Agreement to Pay $1.1 Billion to Avoid Trial for 737 MAX Crashes -- WSJ

23 mag 2025, 20:50 UTC

Discorsi di Mercato

Auto & Transport Roundup: Market Talk

23 mag 2025, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

23 mag 2025, 20:41 UTC

Notizie principali

Stocks Fall on Tariff Broadside, After Week of Bond Market Agita -- WSJ

23 mag 2025, 20:28 UTC

Notizie principali

Trump Threatens EU With 50% Tariffs, Takes Aim at Apple; Nasdaq Drops -- WSJ

23 mag 2025, 20:06 UTC

Notizie principali

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- 5th Update

23 mag 2025, 20:06 UTC

Acquisizioni, Fusioni, Takeovers

Salesforce Stock Drops, Informatica Soars. A Deal May Be Back on the Table. -- Barrons.com

23 mag 2025, 19:50 UTC

Notizie principali

Trump's Tariffs: Where Things Stand -- 16th Update

23 mag 2025, 19:28 UTC

Acquisizioni, Fusioni, Takeovers

Trump on Truth Social: 'Bulk of That Investment Will Occur in the Next 14 Months'

23 mag 2025, 19:28 UTC

Acquisizioni, Fusioni, Takeovers

Trump on Truth Social: 'This Will Be a Planned Partnership Between United States Steel and Nippon Steel'

23 mag 2025, 19:27 UTC

Acquisizioni, Fusioni, Takeovers

Trump on Truth Social: 'Proud to Announce That, After Much Consideration and Negotiation, US Steel Will REMAIN in America'

23 mag 2025, 19:20 UTC

Discorsi di Mercato

Crude Futures Post Modest Weekly Losses -- Market Talk

23 mag 2025, 19:18 UTC

Discorsi di Mercato

U.S. Natural Gas Futures End Week Unchanged -- Market Talk

23 mag 2025, 18:57 UTC

Notizie principali

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- 4th Update

23 mag 2025, 18:54 UTC

Notizie principali

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- Update

23 mag 2025, 18:53 UTC

Notizie principali
Acquisizioni, Fusioni, Takeovers

McDonald's Bids Goodbye to CosMc's, Its Space Alien-Themed Spinoff -- WSJ

23 mag 2025, 18:52 UTC

Acquisizioni, Fusioni, Takeovers

DDC Enterprise Issues 254,333 Class A Ordinary Shrs in Exchange for 21 BTC, Valued at About $2.28M in Current Market Price

23 mag 2025, 18:13 UTC

Discorsi di Mercato

Market Talk Roundup: Latest on U.S. Politics

23 mag 2025, 18:13 UTC

Discorsi di Mercato

Gold Trades Higher on Reminder of Risk -- Market Talk

23 mag 2025, 18:00 UTC

Notizie principali

Apple's Stock Still Not Pricing in Trump's Demands - Heard on the Street -- WSJ

23 mag 2025, 17:51 UTC

Discorsi di Mercato
Utili

Workday Sees Higher Bar for Guidance -- Market Talk

23 mag 2025, 17:42 UTC

Notizie principali

Dow Drops, Trump Threatens EU With 50% Tariffs, Takes Aim at Apple -- WSJ

Confronto tra pari

Modifica del prezzo

Fulgent Genetics Inc Previsione

Obiettivo di Prezzo

By TipRanks

10.48% in crescita

Previsioni per 12 mesi

Media 22.67 USD  10.48%

Alto 25 USD

Basso 20 USD

Basato su 3 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Fulgent Genetics Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

3 ratings

1

Acquista

2

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

17.32 / 19.04Supporto e resistenza

A breve termine

Bearish Evidence

A termine intermedio

Strong Bullish Evidence

A lungo termine

Neutral Evidence

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Fulgent Genetics Inc

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.